Source: Annual Congress 2011 - Physiological basis of respiratory disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Lock Johansson, Q. Tan, A. Schlosser, I. Titlestad, U. Holmskov, K. Kyvik, G. Sørensen (Odense, Denmark). Late-breaking abstract: Association between serum surfactant protein D (SP-D) and lung function measurements in self-reported healthy twins. Eur Respir J 2011; 38: Suppl. 55, 4730

Member's Comments

No comment yet.

Related content which might interest you: Late-breaking abstract: Surfactant protein D (SP-D) as a biomarker for mortality: A study in elderly Danish twins Source: Annual Congress 2011 - Lung cell biology Year: 2011 Plasma surfactant protein D (SP-D) and smoking status in patients with COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014 Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Early stage asymptomatic (HRCT detectable) patients with IPF showed augmented serum surfactant protein D (SP-D) Source: Eur Respir J 2002; 20: Suppl. 38, 61s Year: 2002 Plasma surfactant protein D (SP-D) and comorbidity rate in patients with COPD Source: International Congress 2014 – Predictors Year: 2014 Serum surfactant protein D (SPD) as a specific marker for COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 COPD: Acute exacerbation (AE) rate and saturation in the patients with different plasma surfactant protein D (SP-D) level Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Association between serum clara cell secretory protein (CC-16) levels and asthma-related phenotypes among adults from the EGEA study Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Sputum Vitamin D binding protein (VDBP) GC1S/1S genotype predicts airway obstruction: a prospective study in smokers with COPD Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Association between serum levels of clara cell secretory protein and lung function in adults from ECRHS Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012 The relationship of vitamin D binding protein polymorphisms with blood vitamin D Level in Korean patients with COPD Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015 Serum surfactant protein D (SPD) and response to the combined therapy in patients (pts) with stable COPD Source: Annual Congress 2012 - COPD treatment and varia Year: 2012 COPD: Acute exacerbation (AE) and hospitalization rate (HR) in patients with different serum surfactant protein D (SPD) level Source: Annual Congress 2012 - COPD exacerbation Year: 2012 Response to the combined therapy in COPD patients (pts) with different plasma surfactant protein D (SPD) level Source: International Congress 2014 – COPD markers Year: 2014 Surfactant protein D (SPD) and C-reactive protein (CRP) levels in patients (pts) with community acquired pneumonia (CAP) during the treatment program Source: International Congress 2014 – Clinical problems in acute and chronic lung diseases Year: 2014 High-sensitive C-reactive protein is associated with reduced lung function in young adults Source: Eur Respir J 2009; 33: 382-388 Year: 2009 Serum SP-A and SP-D: Different cutoff values for German and Japanese patients to diagnose idiopathic interstitial pneumonia Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Lung clearance index (LCI) and trapped gas (TG) may reflect different aspects of Cystic Fibrosis (CF) lung disease in infants Source: Eur Respir J 2003; 22: Suppl. 45, 228s Year: 2003 “Plasma pro-surfactant protein B and lung function decline in smokers.” Source: Eur Respir J 2016; 48: 962 Year: 2016